Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines

Etsuko Matsuzaki, Shunji Hiratsuka, Takafumi Hamachi, Fumi Takahashi-Yanaga, Yoko Hashimoto, Katsumasa Higashi, Mari Kobayashi, Takao Hirofuji, Masato Hirata, Katsumasa Maeda

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Sphingosine-1-phosphate (S1P) is a well-known signaling sphingolipid and bioactive lipid mediator. Recently, it was reported that S1P inhibits osteoclast differentiation and bone resorption. On the other hand, S1P effects on osteoblasts and bone formation are little known. In this study, we investigated the effects of S1P on osteoblasts, using two osteoblast-like cell lines, SaOS-2 and MC3T3-E1. S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells. The inhibitors of PI3K and Akt suppressed S1P-induced nuclear localization of β-catenin. We further investigated the effects of PI3K/Akt signaling on the Wnt/β-catenin signaling pathway, since β-catenin takes a central role in this signaling pathway. Both inhibitors for PI3K and Akt suppressed the nuclear localization of β-catenin and T-cell factor transcriptional activity induced by Wnt-3a. S1P increased the amount of osteoprotegerin at both mRNA and protein levels, and increased the activity of alkaline phosphatase, leading to the mineralization. These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.

Original languageEnglish
Pages (from-to)315-324
Number of pages10
JournalBone
Volume55
Issue number2
DOIs
Publication statusPublished - Aug 1 2013

Fingerprint

Osteoprotegerin
Catenins
Osteoblasts
Phosphatidylinositol 3-Kinase
Gene Expression
Cell Line
TCF Transcription Factors
Osteoclasts
Alkaline Phosphatase
Glycogen Synthase Kinase 3
Sphingolipids
Wnt Signaling Pathway
sphingosine 1-phosphate
Differentiation Antigens
Bone Resorption
Osteogenesis
Up-Regulation
Lipids
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Histology

Cite this

Matsuzaki, E., Hiratsuka, S., Hamachi, T., Takahashi-Yanaga, F., Hashimoto, Y., Higashi, K., ... Maeda, K. (2013). Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. Bone, 55(2), 315-324. https://doi.org/10.1016/j.bone.2013.04.008

Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. / Matsuzaki, Etsuko; Hiratsuka, Shunji; Hamachi, Takafumi; Takahashi-Yanaga, Fumi; Hashimoto, Yoko; Higashi, Katsumasa; Kobayashi, Mari; Hirofuji, Takao; Hirata, Masato; Maeda, Katsumasa.

In: Bone, Vol. 55, No. 2, 01.08.2013, p. 315-324.

Research output: Contribution to journalArticle

Matsuzaki, E, Hiratsuka, S, Hamachi, T, Takahashi-Yanaga, F, Hashimoto, Y, Higashi, K, Kobayashi, M, Hirofuji, T, Hirata, M & Maeda, K 2013, 'Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines', Bone, vol. 55, no. 2, pp. 315-324. https://doi.org/10.1016/j.bone.2013.04.008
Matsuzaki, Etsuko ; Hiratsuka, Shunji ; Hamachi, Takafumi ; Takahashi-Yanaga, Fumi ; Hashimoto, Yoko ; Higashi, Katsumasa ; Kobayashi, Mari ; Hirofuji, Takao ; Hirata, Masato ; Maeda, Katsumasa. / Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. In: Bone. 2013 ; Vol. 55, No. 2. pp. 315-324.
@article{0bc7bc09d41a464a875f75b6a123d948,
title = "Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines",
abstract = "Sphingosine-1-phosphate (S1P) is a well-known signaling sphingolipid and bioactive lipid mediator. Recently, it was reported that S1P inhibits osteoclast differentiation and bone resorption. On the other hand, S1P effects on osteoblasts and bone formation are little known. In this study, we investigated the effects of S1P on osteoblasts, using two osteoblast-like cell lines, SaOS-2 and MC3T3-E1. S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells. The inhibitors of PI3K and Akt suppressed S1P-induced nuclear localization of β-catenin. We further investigated the effects of PI3K/Akt signaling on the Wnt/β-catenin signaling pathway, since β-catenin takes a central role in this signaling pathway. Both inhibitors for PI3K and Akt suppressed the nuclear localization of β-catenin and T-cell factor transcriptional activity induced by Wnt-3a. S1P increased the amount of osteoprotegerin at both mRNA and protein levels, and increased the activity of alkaline phosphatase, leading to the mineralization. These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
author = "Etsuko Matsuzaki and Shunji Hiratsuka and Takafumi Hamachi and Fumi Takahashi-Yanaga and Yoko Hashimoto and Katsumasa Higashi and Mari Kobayashi and Takao Hirofuji and Masato Hirata and Katsumasa Maeda",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.bone.2013.04.008",
language = "English",
volume = "55",
pages = "315--324",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines

AU - Matsuzaki, Etsuko

AU - Hiratsuka, Shunji

AU - Hamachi, Takafumi

AU - Takahashi-Yanaga, Fumi

AU - Hashimoto, Yoko

AU - Higashi, Katsumasa

AU - Kobayashi, Mari

AU - Hirofuji, Takao

AU - Hirata, Masato

AU - Maeda, Katsumasa

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Sphingosine-1-phosphate (S1P) is a well-known signaling sphingolipid and bioactive lipid mediator. Recently, it was reported that S1P inhibits osteoclast differentiation and bone resorption. On the other hand, S1P effects on osteoblasts and bone formation are little known. In this study, we investigated the effects of S1P on osteoblasts, using two osteoblast-like cell lines, SaOS-2 and MC3T3-E1. S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells. The inhibitors of PI3K and Akt suppressed S1P-induced nuclear localization of β-catenin. We further investigated the effects of PI3K/Akt signaling on the Wnt/β-catenin signaling pathway, since β-catenin takes a central role in this signaling pathway. Both inhibitors for PI3K and Akt suppressed the nuclear localization of β-catenin and T-cell factor transcriptional activity induced by Wnt-3a. S1P increased the amount of osteoprotegerin at both mRNA and protein levels, and increased the activity of alkaline phosphatase, leading to the mineralization. These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.

AB - Sphingosine-1-phosphate (S1P) is a well-known signaling sphingolipid and bioactive lipid mediator. Recently, it was reported that S1P inhibits osteoclast differentiation and bone resorption. On the other hand, S1P effects on osteoblasts and bone formation are little known. In this study, we investigated the effects of S1P on osteoblasts, using two osteoblast-like cell lines, SaOS-2 and MC3T3-E1. S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells. The inhibitors of PI3K and Akt suppressed S1P-induced nuclear localization of β-catenin. We further investigated the effects of PI3K/Akt signaling on the Wnt/β-catenin signaling pathway, since β-catenin takes a central role in this signaling pathway. Both inhibitors for PI3K and Akt suppressed the nuclear localization of β-catenin and T-cell factor transcriptional activity induced by Wnt-3a. S1P increased the amount of osteoprotegerin at both mRNA and protein levels, and increased the activity of alkaline phosphatase, leading to the mineralization. These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.

UR - http://www.scopus.com/inward/record.url?scp=84878133071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878133071&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2013.04.008

DO - 10.1016/j.bone.2013.04.008

M3 - Article

C2 - 23612487

AN - SCOPUS:84878133071

VL - 55

SP - 315

EP - 324

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -